Jun 2026 (Q2 FY26) — Aug 12, 2026
Dyadic Q2 FY26 — Commercial Transition Gains Traction Amidst Going Concern Disclosure
Read the full callDyadic (DYAI) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Dyadic earnings: last reported Wed, 12 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 0.96 | −0.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -213.7 | −34.8 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -2.1 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$0.38 −7.32% · −$0.03
Performance −64.5% 1Y
1Y: $1.07 on 17 Oct 2025 → $0.38. High $1.47 (21 Jul 2026), low $0.38 (19 Oct 2026).
- Previous close
- $0.41
- 52-week range
- $0.38 – $1.47
- One year
- −66.37%
Overview
- Symbol
- DYAI
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Dyadic earnings calls (DYAI)
Financials
What the filings say
Net profit, year on year: −18% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Expenses | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 |
| Operating profit | -0 | -2 | -2 | -2 | -2 | -2 | -2 | -2 |
| Operating margin | −10.3% | −187.2% | −508.8% | −178.9% | −165.3% | −271.6% | −171.3% | −213.7% |
| Other income | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -0 | -2 | -2 | -2 | -2 | -2 | -2 | -2 |
| EPS ($ per share) | -0.01 | — | -0.07 | -0.06 | -0.06 | — | -0.05 | -0.06 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -33 | -41 | -51 | -64 | -73 | -80 | -86 | -93 |
| Total liabilities | 1 | 2 | 2 | 3 | 3 | 2 | 7 | 9 |
| Investments | — | — | — | — | — | — | 3 | 3 |
| Total assets | 43 | 37 | 30 | 21 | 14 | 8 | 10 | 10 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -4 | -6 | -7 | -11 | -8 | -7 | -4 | -6 |
| Cash from investing | 3 | 8 | 22 | 5 | -2 | 7 | -2 | 0 |
| Cash from financing | -2 | 1 | 0 | 1 | 1 | 0 | 6 | 5 |
| Net cash flow | -3 | 2 | 16 | -5 | -10 | 1 | -0 | -1 |
Insider filings
10 filings between Jan 2, 2026 and Jul 24, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$125.0K
3 sales by 1 insider
Compensation
not trading decisions- 4
- Award — granted as compensation
- 3
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Francisco Trust under agreement dated February 28, 1996 | — | $125.0K | Jul 24, 2026 |
Latest filings (36)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | 2,616 | $3.2K |
| Jul 23, 2026 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | 54,760 | $71.3K |
| Jul 22, 2026 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | 38,016 | $50.5K |
| Jan 2, 2026 | EMALFARB MARK A CEO | Award | 102,609 | $0 |
| Jan 2, 2026 | Hazelton Joseph P President & COO | Award | 36,418 | $0 |
| Jan 2, 2026 | TCHELET RONEN VP of Research and Bus. Dvlpmt | Award | 18,064 | $0 |
| Jan 2, 2026 | Rawson Ping Wang Chief Financial Officer | Award | 29,158 | $0 |
| Jan 2, 2026 | Lucy Patrick K. Director | Option exercise | 21,552 | — |
| Jan 2, 2026 | Kaye Jack Director | Option exercise | 21,552 | — |
| Jan 2, 2026 | HERBST SETH Director | Option exercise | 21,552 | — |
| Aug 1, 2025 | Hazelton Joseph P President and COO | Purchase | 26,000 | $24.7K |
| Jun 20, 2025 | Bose Arindam Director | Option exercise | 10,776 | — |
| Jun 20, 2025 | Tarnok Michael P. Director | Option exercise | 10,776 | — |
| Mar 5, 2025 | Kaye Jack Director | Option exercise | 7,500 | $10.0K |
| Mar 5, 2025 | Kaye Jack Director | Tax withheld | 27,517 | $39.9K |
| Mar 5, 2025 | Kaye Jack Director | Option exercise | 22,500 | $29.9K |
| Jan 7, 2025 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | 15,000 | $30.2K |
| Jan 6, 2025 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | 20,000 | $38.5K |
| Jan 6, 2025 | HERBST SETH Director | Option exercise | 18,750 | $18.2K |
| Jan 6, 2025 | HERBST SETH Director | Option exercise | 6,250 | $6.1K |
| Jan 2, 2025 | Tarnok Michael P. Director | Option exercise | 23,585 | — |
| Jan 2, 2025 | HERBST SETH Director | Option exercise | 23,585 | — |
| Jan 2, 2025 | Lucy Patrick K. Director | Option exercise | 23,585 | — |
| Jan 2, 2025 | EMALFARB MARK A President and CEO | Award | 73,111 | $0 |
| Jan 2, 2025 | TCHELET RONEN VP of Research and Bus. Dvlpmt | Award | 8,980 | $0 |
| Jan 2, 2025 | Hazelton Joseph P Chief Operating Officer | Award | 30,172 | $0 |
| Jan 2, 2025 | Rawson Ping Wang Chief Financial Officer | Award | 20,776 | $0 |
| Jan 2, 2025 | Bose Arindam Director | Option exercise | 23,585 | — |
| Jan 2, 2025 | Kaye Jack Director | Option exercise | 23,585 | — |
| Dec 30, 2024 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | 40,000 | $79.1K |
| Dec 24, 2024 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | 5,100 | $9.2K |
| Dec 23, 2024 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | 41,143 | $75.6K |
| Dec 20, 2024 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | 25,281 | $47.3K |
| Nov 22, 2024 | Tarnok Michael P. Director | Option exercise | 18,750 | $18.2K |
| Nov 22, 2024 | Tarnok Michael P. Director | Option exercise | 6,250 | $6.1K |
| Jun 6, 2024 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | 26,340 | $63.9K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for DYADIC INTERNATIONAL INC
Free account. Everything above stays public.
Write why you follow DYADIC INTERNATIONAL INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading